Initial phase value of contract is US$8.2 million for 10 patient clinical trial, which if showing successful outcomes may be followed at BARDA’s discretion by a US$18 million 150 patient trial, which if successful will lead to a fully funded PMA pathway to FDA approval valued at a further US$26 Million. Total potential value: US$52.2 million over perhaps 3-4 years. Not bad.
Ann: PolyNovo Awarded BARDA Contract for Burns Trial, page-2
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.58 |
Change
-0.090(3.37%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.62 | $2.53 | $2.926M | 1.140M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 26780 | $2.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.58 | 22793 | 24 |
View Market Depth
| Last trade - 13.43pm 25/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |